Wells Fargo analyst Joseph O’Dea downgraded Emerson (EMR) to Equal Weight from Overweight with a price target of $140, down from $150, as part of a Q3 earnings preview. The firm sees the company’s near-term lacks catalysts with a “downsized” exit rate growth in fiscal 2025 and tough margin compares in the first half of 2026. Valuation expansion for Emerson “likely needs earnings revision help,” the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson Electric Co. Receives ‘Buy’ Rating Amid Strong EPS Performance and Positive Outlook Despite Regional Demand Challenges
- Promising Outlook for Emerson Electric: Buy Rating Affirmed Due to Anticipated Growth in T&M and Discrete Segments
- Emerson Electric: Undervalued Growth Potential with Strategic Investments and Market Positioning
- Emerson upgraded to Equal Weight from Underweight at Barclays
- Emerson Electric Reports Strong Q3 2025 Results